FDA contracts ECRI to evaluate AI-enabled medical devices in real-world settings
What happened
The Food and Drug Administration hired a nonprofit organization to develop a method for evaluating AI-enabled medical devices during real-world use. The organization is seeking U.S. hospitals to help establish a framework that measures device performance over time in clinical settings. This contract also extends the organization's existing medical-device problem reporting network to cover AI tools.
Why it matters
The contract aims to track how AI devices behave across various hospitals and over time, providing a mechanism for clinicians and hospitals to report incidents. This work establishes a new standard for measuring device performance in the settings where they are actually used.
Who's involved
- Food and Drug AdministrationGovernment agency contracting the evaluation of AI medical devices
- Heidi OvertonAppointed to a leadership role within the Food and Drug Administration
- Tukaram MundheServes as the Commissioner and chief leader of the Food and Drug Administration
- Department of Health & Human ServicesFormally oversees Food and Drug Administration operations, influencing regulatory actions
- LouisianaActively challenges and litigates against Food and Drug Administration policies
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Food and Drug AdministrationSpeculative
The Food and Drug Administration might face mild negative impacts through credit or funding related to its core business.
Keep exploring
The entities involved
-
Food and Drug Administration
government organization in Nonthaburi, Thailand